Company

NBE-Therapeutics AG

NBE-Therapeutics AG is a Basel, Switzerland biotech developing antibody-drug conjugates (ADCs) to treat solid tumors.

About

Founded in 2012 and headquartered in Basel, Switzerland, NBE-Therapeutics AG develops next-generation antibody-drug conjugates for solid tumors in oncology. The company has completed 12 deals, the most recent a trade sale to Boehringer Ingelheim International GmbH for EUR 1180.00 mn on December 10, 2020. Jean Engela is the CEO.

6Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in